Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome

Background The COVID‐19 pandemic has greatly increased the incidence and clinical importance of critical illness myopathy (CIM), because it is one of the most common complications of modern intensive care medicine. Current diagnostic criteria only allow diagnosis of CIM at an advanced stage, so that...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of cachexia, sarcopenia and muscle Ročník 13; číslo 3; s. 1883 - 1895
Hlavní autori:	Rodriguez, Belén, Branca, Mattia, Gutt‐Will, Marielena, Roth, Marianne, Söll, Nicole, Nansoz, Sandra, Cameron, David R., Tankisi, Hatice, Tan, S. Veronica, Bostock, Hugh, Raabe, Andreas, Schefold, Joerg C., Jakob, Stephan M., Z'Graggen, Werner J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Germany John Wiley & Sons, Inc 01.06.2022 John Wiley and Sons Inc Wiley
Predmet:	Anesthesia Biopsy Coronaviruses COVID-19 Disease transmission Drug dosages Electrodes Electromyography Guillain-Barre syndrome ICU‐acquired weakness Illnesses Intensive care Intubation Laboratories Membrane potential Muscle velocity recovery cycle Nerve conduction studies Neuromuscular blocking agents Original Patients Potassium Propofol Respiratory distress syndrome SARS‐CoV‐2 Sepsis Velocity Ventilators Weaning Switzerland Neuromuscular blocking agents ICU-acquired weakness SARS-CoV-2 Sepsis Electromyography Membrane potential Propofol Nerve conduction studies Muscle velocity recovery cycle
ISSN:	2190-5991, 2190-6009, 2190-6009
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!